Real outcomes. Named industries, anonymized companies. These are the results of fractional CMO engagements led by Mark Gabrielli across 25+ companies.
Every engagement in this portfolio started with the same first step: a commercial diagnostic that identified the specific bottleneck preventing faster pipeline growth. Not a discovery call. Not a strategy deck. A structured audit of the attribution model, the ICP definition accuracy, the channel mix efficiency, and the sales and marketing alignment. In every case, the diagnostic revealed that the commercial problem was not what the company believed it was -- and the fix was not more marketing activity but a structural change to how the commercial system was built.
The pattern across all engagements is consistent. Companies that have been spending on marketing without attribution infrastructure are spending in the dark -- they know marketing is costing money but cannot prove what it is producing. The first 30 days of every engagement are focused on building that attribution clarity, because without it, every subsequent investment decision is a guess. With it, the channel allocation, the content investment, and the demand generation spend all become defensible decisions made from data rather than preference.
The most common structural errors identified across these engagements: ICP definition too broad to target efficiently, attribution model missing or incomplete so pipeline cannot be traced to source, MQL definition not aligned between sales and marketing so qualified leads are not followed up, and channel investment spread too thin across too many platforms to optimize any of them. Fixing these four structural errors accounts for the majority of the pipeline improvement seen in these results. The results are not the product of more creative campaigns -- they are the product of building commercial infrastructure that did not exist before the engagement started.
Across the engagements represented in this portfolio, the average time to first measurable pipeline impact was 28 days from engagement start -- the period required to complete the commercial diagnostic, rebuild the attribution model, and launch the first optimized demand generation campaign. The average pipeline increase over the first 90 days was 2.4x. The average CAC reduction in the first 60 days was 32 percent. These are not exceptional outcomes from exceptional circumstances -- they are the result of applying a consistent commercial diagnostic framework to companies that have the same structural gaps that most B2B companies have at the $3M to $30M revenue stage.
The engagements that produced the largest outcomes had two things in common: the CEO was fully committed to the commercial accountability framework from day one, and the existing marketing team was capable of executing the strategy once the strategic direction was clear. The engagements that underperformed against their initial potential had the opposite characteristics: either the CEO was not engaged with the commercial outcome reporting or the marketing team required more development time than the 90-day timeline allowed. This is not a criticism -- it is context for calibrating expectations. The commercial diagnostic produces its best results when the organization is ready to act on what it reveals.
The companies in this portfolio were not exceptional. They were B2B companies at the $3M to $30M revenue stage with the structural marketing gaps that are typical at that stage: incomplete attribution, broad ICP, misaligned sales and marketing, and channel investment that was not producing data-driven pipeline. If your company has these same characteristics -- if you are spending on marketing without being able to trace spend to pipeline with confidence -- then the commercial diagnostic will identify the same types of structural gaps, and the same types of structural fixes will produce comparable pipeline impact.
The free 30-minute diagnostic call is the first step. It is not a sales presentation -- it is a structured commercial assessment that will identify the specific bottleneck in your pipeline, estimate the impact of fixing it, and tell you whether a fractional CMO engagement is the right solution for your specific situation. If it is not, the diagnostic will tell you that too. The goal is an accurate commercial assessment, not a match.
Every engagement starts with a free 30-minute diagnostic. No pitch, no deck. Just an honest read on where your marketing is breaking down and what it would take to fix it.